A Comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 (United States)
In order to quantify the differences between ultrasound-imaging and megavoltage-CT (MVCT) daily prostate localization in prostate-cancer radiotherapy and their dosimetric impacts, daily shifts were analyzed for a total of 140 prostate cancer patients; 106 positioned using ultrasound-based imaging [B-mode Acquisition and Targeting (BAT)], and 34 using the MVCT from a TomoTherapy Hi-Art unit. The shifts indicated by the two systems were compared statistically along the right/left (R/L), superior/inferior (S/I), and anterior/posterior (A/P) directions. The systematic and random variations among the daily alignments were calculated. Margins to account for these shifts were estimated. The mean shifts and standard deviations along the R/L, S/I, and A/P directions were -0.11{+-}3.80, 0.67{+-}4.67, and 2.71{+-}6.31 mm for BAT localizations and -0.98{+-}5.13, 0.27{+-}3.35, and 1.00{+-}4.22 mm for MVCT localizations, respectively. The systematic and random variations in daily shifts based on MVCT were generally smaller than those based on BAT, especially along the A/P direction. A t-test showed this difference to be statistically significant. The planning target volume margins in the A/P direction estimated to account for daily variations were 8.81 and 14.66 mm based on MVCT and BAT data, respectively. There was no statistically significant difference in the daily prostate movement pattern between the first few fractions and the remaining fractions. Dosimetric comparison of MVCT and BAT prostate alignments was performed for seven fractions from a patient. The degradation from the plan caused by the MVCT alignment is trivial, while that by BAT is substantial. The MVCT technique results in smaller variations in daily shifts than ultrasound imaging, indicating that MVCT is more reliable and precise for prostate localization. Ultrasound-based localization may overestimate the daily prostate motion, particularly in the A/P direction, negatively impacting prostate dose coverage and rectal sparing.
- OSTI ID:
- 22095285
- Journal Information:
- Medical Physics, Journal Name: Medical Physics Journal Issue: 12 Vol. 35; ISSN 0094-2405; ISSN MPHYA6
- Country of Publication:
- United States
- Language:
- English
Similar Records
A Comparison of Soft-Tissue Implanted Markers and Bony Anatomy Alignments for Image-Guided Treatments of Head-and-Neck Cancers
Ultrasound imaging for external-beam prostate treatment setup and dosimetric verification
Clinical assessment of three-dimensional ultrasound prostate localization for external beam radiotherapy
Journal Article
·
Sun Feb 28 23:00:00 EST 2010
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:21372099
Ultrasound imaging for external-beam prostate treatment setup and dosimetric verification
Journal Article
·
Mon Dec 30 23:00:00 EST 2002
· Medical Dosimetry
·
OSTI ID:20655425
Clinical assessment of three-dimensional ultrasound prostate localization for external beam radiotherapy
Journal Article
·
Thu Dec 14 23:00:00 EST 2006
· Medical Physics
·
OSTI ID:20853837